A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 3, 2012, Pages 663-673

  Silva, Sérgio M C ^a,b,c,d,e   Hu, Longsheng ^c,d,e   Sousa, João J S ^a   Pais, Alberto A C C ^b   Michniak Kohn, Bozena B ^c,d,e  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c RUTGERS UNIVERSITY   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

Chemical permeation enhancers; Iontophoresis; Surfactants; Transdermal drug delivery

Indexed keywords

DILTIAZEM; ETHYLENE GLYCOL MONODODECYL ETHER; NONIONIC SURFACTANT; OCTAETHYLENE GLYCOL MONODODECYL ETHER; ONDANSETRON; PENETRATION ENHANCING AGENT; PENTAETHYLENE GLYCOL MONODODECYL ETHER; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DERMATOME; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYDROGEL; IONTOPHORESIS; KERATINOCYTE; MICROSCOPY; MOLECULAR WEIGHT; NONHUMAN; PASSIVE TRANSPORT; SCANNING ELECTRON MICROSCOPY; SKIN CELL; SKIN FIBROBLAST; SKIN PENETRATION; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; DILTIAZEM; DRUG DELIVERY SYSTEMS; FIBROBLASTS; HUMANS; HYDROGELS; IONTOPHORESIS; KERATINOCYTES; ONDANSETRON; PERMEABILITY; PROPYLENE GLYCOL; SKIN; SKIN ABSORPTION; SOLUTIONS; SURFACE-ACTIVE AGENTS; SWINE;

EID: 84858159621     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.11.010     Document Type: Article

References (50)

1. C.B. Archer Functions of the Skin 2010 Wiley Blackwell
2. R. Paus What is the 'true' function of skin? Exp. Dermatol. 11 2002 159 187
3. G.K. Menon New insights into skin structure: scratching the surface Adv. Drug Deliv. Rev. 54 2002 S3 S17
4. K.C. Madison Barrier function of the skin: "La Raison d'Être" of the epidermis J. Invest. Dermatol. 121 2003 231 241 (Pubitemid 36969895)
5. P.W. Wertz Lipids and barrier function of the skin Acta Derm. Venereol. 208 2000 7 11
6. P.M. Elias Stratum corneum defensive functions: an integrated view J. Invest. Dermatol. 125 2005 183 200 (Pubitemid 41648149)
7. P. Thornton, Advances in the transdermal drug delivery market: market size, leading players, therapeutic focus and innovative technologies, in: Business Insights, 2010.
8. M.B. Brown, G.P. Martin, S.A. Jones, and F.K. Akomeah Dermal and transdermal drug delivery systems: current and future prospects Drug Deliv. 13 2006 175 187
9. R.J. Scheuplein Mechanism of percutaneous adsorption J. Invest. Dermatol. 45 1965 334 346
10. J. Hadgraft Skin, the final frontier Int. J. Pharm. 224 2001 1 18 (Pubitemid 32706481)
11. V.R. Sinha, and M.P. Kaur Permeation enhancers for transdermal drug delivery Drug Dev. Ind. Pharm. 26 2000 1131 1140
12. H.A.E. Benson Transdermal drug delivery: penetration enhancement techniques Curr. Drug Deliv. 2 2005 23 33 (Pubitemid 40590918)
13. K. Moser, K. Kriwet, A. Naik, Y.N. Kalia, and R.H. Guy Passive skin penetration enhancement and its quantification in vitro Eur. J. Pharm. Biopharm. 52 2001 103 112 (Pubitemid 32755887)
14. J.A.S. Almeida, E.F. Marques, A.S. Jurado, and A.A.C.C. Pais The effect of cationic gemini surfactants upon lipid membranes. An experimental and molecular dynamics simulation study Phys. Chem. Chem. Phys. 12 2010 14462 14476
15. I. Effendy, and H.I. Maibach Surfactants and experimental irritant contact dermatitis Contact Dermatitis 33 1995 217 225
16. M. Bergh Allergenic oxidation products Acta Derm. Venereol. 79 1999 5 26
17. Y. Wang, R. Thakur, Q. Fan, and B. Michniak Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery Eur. J. Pharm. Biopharm. 60 2005 179 191 (Pubitemid 40804560)
18. Y.N. Kalia, A. Naik, J. Garrison, and R.H. Guy Iontophoretic drug delivery Adv. Drug Deliv. Rev. 56 2004 619 658 (Pubitemid 38326937)
19. M. Artusi, S. Nicoli, P. Colombo, R. Bettini, A. Sacchi, and P. Santi Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro J. Pharm. Sci. 93 2004 2431 2438 (Pubitemid 39319427)
20. Y. Wang, Q. Fan, Y. Song, and B. Michniak Effects of fatty acids and iontophoresis on the delivery of midodrine hydrochloride and the structure of human skin Pharm. Res. 20 2003 1612 1618 (Pubitemid 37268277)
21. F. Bounoure, M. Lahiani Skiba, M. Besnard, P. Arnaud, E. Mallet, and M. Skiba Effect of iontophoresis and penetration enhancers on transdermal absorption of metopimazine J. Dermatol. Sci. 52 2008 170 177
22. Y.N. Kalia, and R.H. Guy Interaction between penetration enhancers and iontophoresis: effect on human skin impedance in vivo J. Control. Release 44 1997 33 42 (Pubitemid 27051332)
23. K.S. Bhatia, S. Gao, and J. Singh Effect of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability through porcine skin J. Control. Release 47 1997 81 89 (Pubitemid 27154403)
24. L.M.A. Nolan, J. Corish, O.I. Corrigan, and D. Fitzpatrick Combined effects of iontophoretic and chemical enhancement on drug delivery: II. Transport across human and murine skin, Int. J. Pharm. 341 2007 114 124 (Pubitemid 47088117)
25. V.M. Meidan, M. Al-Khalili, and B.B. Michniak Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers Int. J. Pharm. 264 2003 73 83 (Pubitemid 37297635)
26. S.S. Vaghani, M. Gurjar, S. Singh, S. Sureja, S. Koradia, N.P. Jivani, and M.M. Patel Effect of iontophoresis and permeation enhancers on the permeation of an acyclovir gel Curr. Drug Deliv. 7 2010 329 333
27. A. Faruk, G. Singh, and M.P.S. Ishar In vitro passive and iontophoretically assisted transport of salbutamol sulphate through hairless mice skin Int. J. Pharm. Sci. Nanotechnol. 3 2010 811 818
28. R. Prasad, V. Koul, S. Anand, and R.K. Khar Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: In vitro study Int. J. Pharm. 333 2007 70 78 (Pubitemid 46283271)
29. V.B. Nair, and R. Panchagnula The effect of pretreatment with terpenes on transdermal iontophoretic delivery of arginine vasopressin Il Farmaco 59 2004 575 581 (Pubitemid 38844816)
30. P. Sebastiani, S. Nicoli, and P. Santi Effect of lactic acid and iontophoresis on drug permeation across rabbit ear skin Int. J. Pharm. 292 2005 119 126 (Pubitemid 40255793)
31. H.D.C. Smyth, G. Becket, and S. Mehta Effect of permeation enhancer pretreatment on the iontophoresis of luteinizing hormone releasing hormone (LHRH) through human epidermal membrane (HEM) J. Pharm. Sci. 91 2002 1296 1307 (Pubitemid 34651191)
32. S. Sweetman Martindale: The Complete drug Reference 2006 The Pharmaceutical Press
33. H.S. Gwak, I.S. Oh, and I.K. Chun Transdermal delivery of ondansetron hydrochloride: effects of vehicles and penetration enhancers Drug Dev. Ind. Pharm. 30 2004 187 194 (Pubitemid 38420263)
34. H.S. Gwak, I.S. Oh, and I.K. Chun In vitro percutaneous absorption of ondansetron hydrochloride from pressure-sensitive adhesive matrices through hairless mouse skin Arch. Pharm. Res. 26 2003 644 648
35. P. Ding, H. Xu, G. Wei, and J. Zheng Microdialysis sampling coupled to HPLC for transdermal delivery study of ondansetron hydrochloride in rats Biomed. Chromatogr. 14 2000 141 143 (Pubitemid 30255897)
36. E. Limpongsa, and K. Umprayn Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system AAPS PharmSciTech 9 2008 464 470
37. R. Gupta, and B. Mukherjee Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone-ethylcellulose matrices Drug Dev. Ind. Pharm. 29 2003 1 7 (Pubitemid 36205876)
38. H.A. Ahad, K.K. Reddy, I.B. Md, H.K. C, and C.S. Kumar Formulation and Permeation Studies of Diltiazem Hydrochloride-Ficus Bengalensis Fruit Mucilage Transdermal Patches J. Pharm. Res. 3 2010 928 932
39. N.B. Patel, R.N. Sonpal, S. Mohan, and S. Selvaraj Formulation and evaluation of iontophoretic transdermal delivery of diltiazem hydrochloride Int. J. Res. Pharm. Sci. 1 2010 338 344
40. W. Meyer, R. Schwarz, and K. Neurand The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig Curr. Probl. Dermatol. 7 1978 39 52
41. E.J. Calabrese Gastrointestinal and dermal absorption: interspecies differences Drug Metab. Rev. 15 1984 1013 1032 (Pubitemid 15158035)
42. A.M. Barbero, and H.F. Frasch Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review Toxicol. In Vitro 23 2009 1 13
43. W.G. Reifenrath, E.M. Chellquist, E.A. Shipwash, and W.W. Jederberg Evaluation of animal models for predicting skin penetration in man Fundam. Appl. Toxicol. 4 1984 S224 S230
44. M. Hoppert Microscopic techniques in biotechnology Microscopic Techniques in Biotechnology 2003 Wiley-VCH Veinheim 114
45. R. Ellis, Ellis Hematoxylin and Eosin (H&E) Staining Protocol, 2010.
46. B. Arechabala, C. Coiffard, P. Rivalland, L.J.M. Coiffard, and Y.D. Roeck-Holtzhauer Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release J. Appl. Toxicol. 19 1999 163 165 (Pubitemid 29225005)
47. J.H.C.H.C. Eun, S.Y. Jung, K.H. Cho, and K.H. Kim A comparative study of the cytotoxicity of skin irritants on cultured human oral and skin keratinocytes Brit. J. Dermatol. 130 1994 24 28 (Pubitemid 24201132)
48. H.C. Korting, S. Schindler, A. Hartinger, M. Kerscher, T. Angerpointner, and H.I. Maibach MTT-assay and neutral red release (NRR)-assay: relative role in the prediction of the irritancy potential of surfactants Life Sci. 55 1994 533 540 (Pubitemid 24230340)
49. Y. Song, C. Xiao, R. Mendelsohn, T. Zheng, L. Strekowski, and B. Michniak Investigation of iminosulfuranes as novel transdermal penetration enhancers: enhancement activity and cytotoxicity Pharm. Res. 22 2005 1918 1925 (Pubitemid 41504345)
50. A.F. El-Kattan, C.S. Asbill, and B.B. Michniak The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems Int. J. Pharm. 198 2000 179 189 (Pubitemid 30184855)